No black box warning on record for Breyanzi
As of the latest FDA labeling reviewed, Breyanzi (LISOCABTAGENE MARALEUCEL) does not carry a black box warning. Standard warnings and precautions still apply — see the full Breyanzi medicine page for the complete safety profile.